Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
ZIM Integrated Shipping Services
ZIM
$3.23B
| $389K | ﹤0.01% |
24,174
-739
| -3% | -$11.6K |
|
3827
Stratasys
SSYS
$779M
| $388K | ﹤0.01% |
33,862
| – | – |
|
|
DOO
3828
Bombardier Recreational Products
DOO
$4.75B
| $388K | ﹤0.01% |
8,013
-1,266
| -14% | -$50K |
|
3829
Lifecore Biomedical
LFCR
$179M
| $388K | ﹤0.01% |
47,775
+22,321
| +88% | +$150K |
|
3830
Symbotic
SYM
$5.43B
| $387K | ﹤0.01% |
9,965
+951
| +11% | +$24.9K |
|
3831
Monte Rosa Therapeutics
GLUE
$1.35B
| $387K | ﹤0.01% |
85,712
+39,502
| +85% | +$176K |
|
3832
Skillsoft
SKIL
$78.4M
| $386K | ﹤0.01% |
24,200
+7,941
| +49% | +$150K |
|
3833
ChargePoint
CHPT
$160M
| $386K | ﹤0.01% |
27,440
-18,090
| -40% | -$242K |
|
3834
Five Point Holdings
FPH
$372M
| $385K | ﹤0.01% |
70,087
| – | – |
|
3835
Baytex Energy
BTE
$3B
| $384K | ﹤0.01% |
214,550
-69,639
| -25% | -$122K |
|
3836
SkinHealth Systems
SKIN
$85.9M
| $383K | ﹤0.01% |
200,512
+119,742
| +148% | +$169K |
|
3837
CALL
Lumentum
LITE
$78B
| $380K | ﹤0.01% |
+4,000
| New | +$284K |
|
3838
ARK Genomic Revolution ETF
ARKG
$1.78B
| $380K | ﹤0.01% |
15,601
-20,774
| -57% | -$455K |
|
3839
SELLAS Life Sciences
SLS
$2.5B
| $378K | ﹤0.01% |
+172,803
| New | +$265K |
|
3840
Expensify
EXFY
$202M
| $378K | ﹤0.01% |
146,015
-25,119
| -15% | -$64.2K |
|
3841
Pure Cycle
PCYO
$273M
| $378K | ﹤0.01% |
35,256
+14,313
| +68% | +$148K |
|
3842
Norwood Financial Corp
NWFL
$376M
| $377K | ﹤0.01% |
14,641
+6,245
| +74% | +$156K |
|
|
SEPN
3843
Septerna Inc
SEPN
$2.11B
| $377K | ﹤0.01% |
35,706
+12,973
| +57% | +$107K |
|
3844
Inspired Entertainment
INSE
$164M
| $377K | ﹤0.01% |
46,130
+21,020
| +84% | +$163K |
|
3845
PCB Bancorp
PCB
$400M
| $376K | ﹤0.01% |
17,922
+7,012
| +64% | +$136K |
|
3846
Paymentus
PAY
$5.31B
| $375K | ﹤0.01% |
11,453
+5,838
| +104% | +$195K |
|
3847
Omeros
OMER
$1.26B
| $374K | ﹤0.01% |
124,831
+43,490
| +53% | +$217K |
|
3848
Anika Therapeutics
ANIK
$283M
| $374K | ﹤0.01% |
35,390
+7,379
| +26% | +$93.1K |
|
|
ESSA
3849
DELISTED
ESSA Bancorp
ESSA
| $374K | ﹤0.01% |
19,268
+4,702
| +32% | +$86.9K |
|
3850
NACCO Industries
NC
$316M
| $373K | ﹤0.01% |
8,414
+2,665
| +46% | +$96.6K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.